Patents by Inventor Carl Anthony Blau

Carl Anthony Blau has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • QUANTITATIVE/SEMI-QUANTITATIVE MEASUREMENT OF EPOR ON CANCER CELLS
    Publication number: 20100297639
    Abstract: The present invention provides for assays useful in predicting whether a cancer patient risks suffering erythropoietin-induced tumor progression if treated with erythropoietin. More specifically, one embodiment provides for a validated quantitative reverse transcriptase polymerase chain reaction assay that detects erythropoietin receptor expression, thus indicating whether a cancer patient risks suffering erythropoietin-induced tumor progression if treated with erythropoietin.
    Type: Application
    Filed: October 8, 2008
    Publication date: November 25, 2010
    Applicant: UNIVERSITY OF WASHINGTON through its Center for Commercialization
    Inventors: Christopher P. Miller, Carl Anthony Blau, Michael Henke
  • Methods of controlling cell differentiation and growth using a fusion protein and a drug
    Patent number: 7754202
    Abstract: This invention involves methods and materials for conferring a direct proliferative advantage on a genetically modified subpopulation of cells. Selection is then accomplished by exerting a positive selective stimulus on the engineered cells rather than a negative pressure on nonengineered cells.
    Type: Grant
    Filed: January 7, 1999
    Date of Patent: July 13, 2010
    Assignees: Stanford University, University of Washington
    Inventors: Carl Anthony Blau, David M. Spencer